Rothblatt Martine A

Chairperson &CEO | Director

2 companies

Insider Signal Score

Good

Trades Analyzed

303

12M Win Rate

53.6%

Avg 3M Return

-6.6%

Avg 12M Return

-1.6%

Rothblatt Martine A is a Chairperson &CEO at UNITED THERAPEUTICS Corp with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 130 sells.

Estimated insider holdings value: $23.5M based on current market prices.

Holdings by Company

UTHR6d ago

Current Shares43.6K

Value$23.33M

Net Activity-333,069

Bought: 0Sold: 333.1K

BETAJun 11, 2026

Current Shares8.2K

Value$128.4K

Net Activity0

Bought: 0Sold: 0

Transaction History

Showing 10 filings (page 9)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 2, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	30,000	$228.69	$6,860,825.07	-23.4%	+39.6%	+36.6%
Mar 28, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	29,125	$239.05	$6,962,298.44	-17.3%	+38.8%	+33.6%
Mar 26, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	30,000	$245.84	$7,375,339.23	-24.4%	+28.7%	+25.4%
Mar 22, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	30,000	$236.70	$7,100,981.03	-31.0%	+29.9%	+31.6%
Mar 20, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	30,000	$236.27	$7,088,195.57	-28.0%	+29.3%	+32.5%
Mar 18, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	30,000	$235.54	$7,066,147.21	-31.3%	+27.0%	+34.3%
Mar 14, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	30,000	$240.31	$7,209,192.46	-37.6%	+18.4%	+29.0%
Mar 12, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	30,000	$247.98	$7,439,303.04	-33.3%	+11.5%	+24.4%
Mar 8, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	30,000	$241.07	$7,232,240.60	-22.3%	+13.7%	+30.0%
Mar 6, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	21,300	$234.68	$4,998,678.79	-22.2%	+15.3%	+29.8%

← PrevPage 9Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC